Pyrosequencing of the BRAFV600E Mutation

This study has been completed.
Sponsor:
Information provided by:
Chungnam National University
ClinicalTrials.gov Identifier:
NCT00551486
First received: October 30, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted

October 30, 2007
October 30, 2007
June 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Pyrosequencing of the BRAFV600E Mutation
Diagnostic Value of Pyrosequencing for the BRAFV600E Mutation in Ultrasound-Guided Fine-Needle Aspiration Biopsy Samples of Thyroid Incidentalomas

To investigate the diagnostic efficiency of pyrosequencing for the mutant BRAF allele in ultrasound (US)-guided fine needle aspiration biopsies (FNAB) of thyroid incidentalomas.

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Fine needle aspiration samples of thyroid nodule

Non-Probability Sample
  1. Patients with thyroid nodule larger than 1 cm, or nodule smaller than 1 cm that required further evaluation because of suspicious ultrasound findings
  2. The average size of the nodules was 1.0 cm.
Thyroid Neoplasms
Procedure: ultrasound-guided fine needle aspiration biopsy
Fine needle aspiration (FNA)with cytologic analysis has become a mainstay of thyroid nodule evaluation was used. Nonpalpable nodules were aspirated under ultrasound guidance to facilitate precise targeting of the nodule and to sample the part most likely to improve diagnostic yield.
1
Patients with thyroid incidentaloma underwent ultrasound-guided fine needle aspiration biopsy
Intervention: Procedure: ultrasound-guided fine needle aspiration biopsy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
101
December 2006
Not Provided

Inclusion Criteria:

  • Patients with thyroid nodule larger than 1 cm, or nodule smaller than 1 cm that required further evaluation because of suspicious ultrasound findings

Exclusion Criteria:

  • Patients who refuse participation.
Both
20 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT00551486
071027
Yes
Not Provided
Chungnam National University
Not Provided
Study Director: Minho Shong, M.D., Ph.D. Chungnam National University
Chungnam National University
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP